English (UK)
中文版Galixir 
Founded in 2019, Galixir aspires to be an engine to fuel up the whole pharmaceutical industry leveraging its world-leading AI technologies.
We have a team with solid background in both AI and pharmaceutical science. Our core team members come from MIT, Yale, Johns Hopkins, THU, PKU and other top universities, as well as leading pharma and tech companies.
We have a team with solid background in both AI and pharmaceutical science. Our core team members come from MIT, Yale, Johns Hopkins, THU, PKU and other top universities, as well as leading pharma and tech companies.
Justin Qin
Strategy and Business Development VPGan&Lee Pharmaceuticals
Founded in 1998, Gan & Lee Pharmaceuticals is a high-tech biopharmaceutical company specialized in research, development, production and commercialization of insulin and its analogues, leading in the diabetes market in China.
晓婷 郑
BD高级经理Geneception Inc.
Geneception is an innovation-driven biopharmaceutical company focusing on gene and cell therapy medicines.
Dr. Amber Cai
CEOGenetron Health
Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH) is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive oncology portfolio that covers the entire spectrum of cancer management, addressing needs and challenges from early screening, diagnosis and treatment recommendations, as well as continuous disease monitoring and care. Genetron Health also partners with global biopharmaceutical companies and offers customized services and products.
Mr. Evan Xu
Chief Financial OfficerGenova Inc
Genova Inc., a bio-pharma company dedicated in the innovation of better protein-drugs for viral diseases, cancer and auto-immune diseases. Novaferon ，the first novel protein drug of Genova, shows antiviral efficacy on viral clearance in a proof of concept randomized clinical trial and approved by Healthcare Canada and PMDA of Japan entering into phase 3 multinational centers clinical trial in last December. We are right looking for strategic parthership with big pharma. Contact: ctxu@genova.cn
Responsive Web Design powered by 